Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nagaileben Co's Other Operating Expense for the
three
months ended in Feb. 2026 was 円990 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 was 円3,249 Mil.
Nagaileben Co's quarterly Other Operating Expense
declined
from Aug. 2025 (円752 Mil) to Nov. 2025 (円727 Mil) but then
increased
from Nov. 2025 (円727 Mil) to Feb. 2026 (円990 Mil).
Nagaileben Co's annual Other Operating Expense
increased
from Aug. 2023 (円2,219 Mil) to Aug. 2024 (円2,287 Mil) and
increased
from Aug. 2024 (円2,287 Mil) to Aug. 2025 (円2,381 Mil).
Nagaileben Co Other Operating Expense Related Terms
Nagaileben Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Nagaileben Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,249 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円3,249 Mil mean?
Nagaileben Co (TSE:7447) has a Other Operating Expense of 円3,249 Mil as of Feb. 2026. Other operating expenses that a company records on its income statement. View historical data on Nagaileben Co and its competitors.
Is Nagaileben Co's Other Operating Expense too high?
Nagaileben Co's current Other Operating Expense is 円3,249 Mil. Overall, Nagaileben Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nagaileben Co's Other Operating Expense compare to RL and LEVI?
Nagaileben Co's Other Operating Expense of 円3,249 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Manufacturing - Apparel & Accessories company?
A good Other Operating Expense depends on the Manufacturing - Apparel & Accessories industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Nagaileben Co and its competitors. Nagaileben Co's current Other Operating Expense is 円3,249 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nagaileben Co stock overvalued right now?
Based on GuruFocus' analysis, Nagaileben Co (TSE:7447) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,242.29, compared to a current price of 円1,787.00 — trading 20.3% below its estimated fair value. The current Other Operating Expense is 円3,249 Mil. Nagaileben Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Nagaileben Co (TSE:7447), the current Other Operating Expense is 円3,249 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nagaileben Co (TSE:7447) Overvalued in 2026?
Based on GuruFocus' analysis, Nagaileben Co stock appears to be undervalued.
The current stock price of 円1,787.00 is trading 20.3% below its estimated GF Value™ of 円2,242.29.
GuruFocus considers Nagaileben Co to be Modestly Undervalued.
Key valuation signals for TSE:7447:
Other Operating Expense: 円3,249 Mil
GF Value™: 円2,242.29 vs. price of 円1,787.00 (20.3% below fair value)
No single metric tells the full story. See the TSE:7447 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nagaileben Co Ltd manufactures and sells medical clothing and shoes for doctors, dentists, pharmacists, nursing staff, patients, and care workers. Nearly all the company's sales are in Japan, with more than half of total sales in east Japan and the remaining Japanese sales in central Japan and west Japan. The company's six item segments are healthcare wear, surgery wear, doctor wear, utility wear, patient wear, and shoes. Healthcare wear accounts for more than half of total company revenue. Doctors' wear, patient wear, and surgery wear constitute most of the remaining revenue. The company manufactures its products in Japan and Indonesia.
61GF Score
Get the complete analysis for TSE:7447
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7447 has been successfully added to your 
